QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

CLFTICKER

Cleveland-Cliffs Inc.

BULLISH stock

Congress has disclosed 4 buys and 8 sells of CLF (Cleveland-Cliffs Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

4
Buy
8
Sell
-4
Net
5
Active politicians
Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Mining. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/B
1.43
▼ cheaper than Mining (median 3.0)
how it's calculated
P/B = price ÷ book value per share
$14.25 ÷ $9.97 = 1.43
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
16.47
≈ in line with Mining (median 16.5)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($8.1B + $7.6B net debt) ÷ $1.0B = $15.7B ÷ $1.0B = 16.47
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

13 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Thomas Tuberville Senate SELL ◆ insider divergence · strong Joint 2024-05-13 814 days — $100K–$250K 50.9 ↗ eFD
Thomas Tuberville Senate OTHER Joint 2024-05-13 814 days — $100K–$250K 50.9 ↗ eFD
Thomas Tuberville Senate SELL ◆ insider divergence · strong Joint 2024-05-10 817 days — $100K–$250K 68.1 ↗ eFD
Thomas Tuberville Senate SELL ◆ insider divergence · strong Joint 2024-05-10 817 days — $50K–$100K 61.4 ↗ eFD
Thomas Tuberville Senate SELL ◆ insider divergence · strong Joint 2024-05-10 817 days — $15K–$50K 56.6 ↗ eFD
Thomas Tuberville Senate SELL ◆ insider divergence · strong Joint 2024-05-10 817 days — $1K–$15K 40.4 ↗ eFD
Thomas Tuberville Senate BUY CALL ◆ insider convergence · strong Joint 2024-05-10 817 days — $1K–$15K 40.4 ↗ eFD
Thomas Tuberville Senate BUY CALL ◆ insider convergence · strong Joint 2024-05-07 820 days — $1K–$15K 75.9 ↗ eFD
Daniel Goldman House SELL ◆ insider divergence · strong Self 2023-06-29 33 days — $1K–$15K
<0.1% of NW
40.4 ↗ filing
Daniel Goldman House BUY ◆ insider convergence · strong Self 2023-04-10 23 days — $1K–$15K
<0.1% of NW
75.9 ↗ filing
Kim Schrier House SELL Joint 2021-10-28 1 days — $15K–$50K
0.2% of NW
92.2 ↗ filing
Warren Davidson House SELL Self 2020-09-21 0 days — $15K–$50K
0.6% of NW
97.9 ↗ filing
Brad Ashford House BUY Self 2016-12-02 4 days — $1K–$15K 75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in CLF — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

3
Congress trades with insider convergence
6
…with insider divergence
32
Insider open-market trades

Of the congressional trades in CLF, 3 coincided with corporate insiders moving the same way within 60 days, and 6 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-10-22 Camara Edilson Director BUY $100K ↗ EDGAR
2026-06-05 Goncalves Celso L Jr C-suite SELL $2.9M ↗ EDGAR
2026-02-17 Smith Clifford T C-suite SELL $2.1M ↗ EDGAR
2026-02-13 Camara Edilson Director BUY $200K ↗ EDGAR
2026-02-11 GONCALVES LOURENCO C-suite SELL $37.3M ↗ EDGAR
2025-05-23 Graham James D C-suite SELL $822K ↗ EDGAR
2025-03-10 BALDWIN JOHN T Director BUY $35K ↗ EDGAR
2025-02-28 CRONIN JANE M. Director BUY $106K ↗ EDGAR
2025-02-28 Koci Keith C-suite BUY $103K ↗ EDGAR
2024-11-20 Bloom Ron A. Director SELL $18K ↗ EDGAR
2024-08-01 BALDWIN JOHN T Director BUY $116K ↗ EDGAR
2024-06-13 BALDWIN JOHN T Director BUY $110K ↗ EDGAR
2024-06-13 MICHAEL RALPH S III Director BUY $295K ↗ EDGAR
2024-06-12 Goncalves Celso L Jr C-suite BUY $109K ↗ EDGAR
2024-06-12 Oren Ben Director BUY $100K ↗ EDGAR
2024-06-11 Taylor Douglas C Director SELL $535K ↗ EDGAR
2024-05-01 Bloom Ron A. Director BUY $425K ↗ EDGAR
2024-05-01 GONCALVES LOURENCO C-suite BUY $1.0M ↗ EDGAR
2024-03-13 GREEN SUSAN MIRANDA Director SELL $133K ↗ EDGAR
2024-03-06 Yocum Arlene M Director BUY $40K ↗ EDGAR
2024-03-06 GONCALVES LOURENCO C-suite SELL $3.8M ↗ EDGAR
2024-03-06 Smith Clifford T C-suite SELL $554K ↗ EDGAR
2024-03-06 Graham James D C-suite SELL $488K ↗ EDGAR
2024-03-06 Fedor Terry G. Other SELL $554K ↗ EDGAR
2024-02-01 Bloom Ron A. Director BUY $506K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-10-22 Camara Edilson Director BUY $100K
◆ insider 2026-06-05 Goncalves Celso L Jr C-suite SELL $2.9M
◆ insider 2026-02-17 Smith Clifford T C-suite SELL $2.1M
◆ insider 2026-02-13 Camara Edilson Director BUY $200K
◆ insider 2026-02-11 GONCALVES LOURENCO C-suite SELL $37.3M
◆ insider 2025-05-23 Graham James D C-suite SELL $822K
◆ insider 2025-03-10 BALDWIN JOHN T Director BUY $35K
◆ insider 2025-02-28 CRONIN JANE M. Director BUY $106K
◆ insider 2025-02-28 Koci Keith C-suite BUY $103K
◆ insider 2024-11-20 Bloom Ron A. Director SELL $18K
◆ insider 2024-08-01 BALDWIN JOHN T Director BUY $116K
◆ insider 2024-06-13 BALDWIN JOHN T Director BUY $110K
◆ insider 2024-06-13 MICHAEL RALPH S III Director BUY $295K
◆ insider 2024-06-12 Goncalves Celso L Jr C-suite BUY $109K
◆ insider 2024-06-12 Oren Ben Director BUY $100K
◆ insider 2024-06-11 Taylor Douglas C Director SELL $535K
Congress 2024-05-13 Thomas Tuberville SELL $100K–$250K
Congress 2024-05-13 Thomas Tuberville OTHER $100K–$250K
Congress 2024-05-10 Thomas Tuberville SELL $100K–$250K
Congress 2024-05-10 Thomas Tuberville SELL $50K–$100K
Congress 2024-05-10 Thomas Tuberville SELL $15K–$50K
Congress 2024-05-10 Thomas Tuberville SELL $1K–$15K
Congress 2024-05-10 Thomas Tuberville BUY $1K–$15K
Congress 2024-05-07 Thomas Tuberville BUY $1K–$15K

FAQ Common questions

How much has Congress traded CLF?

4 disclosed buys and 8 sells of CLF (Cleveland-Cliffs Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade CLF?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.